HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
about
HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the StomachVariable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients.HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patients.Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma.Human epidermal growth factor receptor 2 testing in gastric cancer: recommendations of an Asia-Pacific task forceHER2 discordance between paired primary gastric cancer and metastasis: a meta-analysis.HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections.The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literatureClinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.Astragalus saponins affect proliferation, invasion and apoptosis of gastric cancer BGC-823 cellsThe coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study.Inducible nitric oxide synthase expression in gastric adenocarcinoma: impact on lymphangiogenesis and lymphatic metastasis.Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients.Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes.HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinomaHuman Epidermal Growth Factor Receptor-2 in Sri Lankan Gastric Carcinoma Patients with Clinicopathological Association and Survival.Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study.Characteristics of Gastric Cancer in Lebanon: a Descriptive Study from a Single Institutional Experience.Role of intravoxel incoherent motion MR imaging in preoperative assessing HER2 status of gastric cancers.Detection and Significance of Human Epidermal Growth Factor Receptor 2 Expression in Gastric AdenocarcinomaCharacterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia.Human Epidermal Growth Factor Receptor 2 Status in Gastric Carcinomas with Distinctive Prevalent Cribriform Component.Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population
P2860
Q26780318-4C6B1AA7-5729-4D22-82CA-035687043677Q33589639-EE14768C-4C28-4A59-BB5E-DF49E1D187CCQ33925610-B886BDD1-313C-498C-B96C-38B398B2056CQ33926592-F8D661BF-CD6B-459D-8727-E1A58586CD46Q34469077-D054016B-B201-4810-94E6-648CE45FED96Q34559419-71FDB5D5-F07E-4FE4-A7DD-B34926FD17B0Q35538755-6B2F0CE4-9B66-4B4C-8FF1-D4B9EDE5EE2AQ35548468-662CECC7-3C10-4E00-BF90-D9E59FD63472Q35815603-F2E7F0FC-848F-4B99-9486-AED20889878EQ35831069-72F769E6-47E2-463E-9A24-566D5FBADDFDQ36317603-7D60DCDA-F393-4D0D-9FB9-0D6D3F622896Q36999892-A9C5A714-2A8C-4DC1-84F9-B81000C8C3D9Q37070721-C88E778A-ED29-42CF-9CD1-53BB310E5C88Q37282257-B08C57AC-D0B0-4DCE-BB92-9FD197A08DE4Q37302936-A7691D20-1413-444A-9E87-F91FB2470DA2Q37376929-6EC32FBA-E167-41C4-A1B7-6E2BA5A4AF9CQ37523508-1EEF6FE8-3977-4E62-A9B8-4DB24E99047EQ37607824-79A97920-2A44-4477-8EAC-D4A85718C556Q37632192-2981A82E-70CC-4CCB-B4F2-5281DA036C4BQ38726662-7408EFDF-3C8D-4F6C-A437-EC8930101B8EQ38853156-A2DB524D-CD35-4FD2-8E6A-B3C7EC216347Q39069439-B14CBC12-77FA-46EA-B937-A32E0F9FE5DFQ40424672-413BCC7B-8FB4-4EF1-BEB4-1B047CA9F874Q41472425-0B6AD905-6243-4554-AEF1-0FD6884BCB46Q41601800-4D6D8C03-4559-4983-A3CC-162D49266182Q47218550-6254F61C-E07A-41A4-899C-FF824E74B258Q54218339-52827CB6-FC6F-478F-86FF-26B07479277DQ55175195-2CFF4DBB-4319-47C1-821C-606862BF4BC5Q55224220-B5883BDD-FEF4-48E0-A346-04F04009FDC1Q58774120-224A7ADB-EC34-49C4-8E99-163DAC0435C6
P2860
HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
HER2 expression and relevant c ...... inoma in a Chinese population.
@en
type
label
HER2 expression and relevant c ...... inoma in a Chinese population.
@en
prefLabel
HER2 expression and relevant c ...... inoma in a Chinese population.
@en
P2093
P2860
P356
P1433
P1476
HER2 expression and relevant c ...... inoma in a Chinese population.
@en
P2093
P2860
P2888
P356
10.1186/1746-1596-8-76
P577
2013-05-09T00:00:00Z
P5875
P6179
1019341870